Ranger Investment Management’s AbbVie ABBV Stock Holding History

Ranger Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38	Closed	-$5.89K	–	94
2023 Q4	$5.89K	Hold	38	–	–	﹤0.01%	94
2023 Q3	$5.66K	Hold	38	–	–	﹤0.01%	90
2023 Q2	$5.12K	Hold	38	–	–	﹤0.01%	93
2023 Q1	$6.06K	Hold	38	–	–	﹤0.01%	87
2022 Q4	$6.14K	Hold	38	–	–	﹤0.01%	86
2022 Q3	$5K	Hold	38	–	–	﹤0.01%	88
2022 Q2	$6K	Hold	38	–	–	﹤0.01%	87
2022 Q1	$6K	Hold	38	–	–	﹤0.01%	88
2021 Q4	$5K	Hold	38	–	–	﹤0.01%	91
2021 Q3	$4K	Hold	38	–	–	﹤0.01%	101
2021 Q2	$4K	Hold	38	–	–	﹤0.01%	101
2021 Q1	$4K	Buy	38 +12	+46%	+$1.28K	﹤0.01%	98
2020 Q4	$3K	Sell	26 -11	-30%	-$1.06K	﹤0.01%	98
2020 Q3	$3K	Hold	37	–	–	﹤0.01%	104
2020 Q2	$4K	Sell	37 -4	-10%	-$352	﹤0.01%	96
2020 Q1	$3K	Hold	41	–	–	﹤0.01%	98
2019 Q4	$4K	Hold	41	–	–	﹤0.01%	109
2019 Q3	$3K	Sell	41 -21	-34%	-$1.44K	﹤0.01%	105
2019 Q2	$5K	Hold	62	–	–	﹤0.01%	108
2019 Q1	$5K	Buy	62 +4	+7%	+$327	﹤0.01%	102
2018 Q4	$5K	Hold	58	–	–	﹤0.01%	107
2018 Q3	$5K	Hold	58	–	–	﹤0.01%	105
2018 Q2	$5K	Hold	58	–	–	﹤0.01%	128
2018 Q1	$5K	Hold	58	–	–	﹤0.01%	126
2017 Q4	$6K	Hold	58	–	–	﹤0.01%	129
2017 Q3	$5K	Hold	58	–	–	﹤0.01%	128
2017 Q2	$4K	Hold	58	–	–	﹤0.01%	137
2017 Q1	$4K	Buy	+58	New	+$3.65K	﹤0.01%	140

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ranger Investment Management's ABBV Position: Q1 2024 in Review

Ranger Investment Management sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 38 shares — an estimated $5.89K sold.

Ranger Investment Management first reported a position in ABBV in Q1 2017 and held it in 28 quarters. The position peaked at $6.14K in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

Ranger Investment Management reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
Ranger Investment Management sold 38 AbbVie shares in Q1 2024, an estimated $5.89K.
Ranger Investment Management first reported a position in AbbVie in Q1 2017 and held it in 28 quarters.
Ranger Investment Management's AbbVie position peaked at $6.14K in Q4 2022.
3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Ranger Investment Management's 13F filing for Q1 2024, filed 15 May 2024.